In-depth characterization of in vivo LPS models

E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany)

Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Session: New treatments for asthma and COPD - experimental evidence
Session type: Electronic Poster Discussion
Number: 313
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Benediktus, R. Goeggel, B. Jung (Biberach, Germany). In-depth characterization of in vivo LPS models. Eur Respir J 2007; 30: Suppl. 51, 313

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Modeling in vitro, ex vivo or in vivo?
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013

A human-like ex vivo preclinical model for aerosol deposition studies
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014

Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018

A comparative study of pulmonary host defense in murine obesity models: Important insights into neutrophil function
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016

Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches
Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases
Year: 2014

Imaging of animal models: in vivo we can learn more
Source: Annual Congress 2008 - Computer-aided imaging of lung parenchyma and airways
Year: 2008

In vivo and in vitro regulation of angiopoietin expression by bacterial lipopolysaccharides (LPS)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008

Hemodynamic and respiratory assessement of an ex vivo perfused rat lung model
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

In vitro and in vivo laboratory models of pleural disease
Source: Eur Respir Monogr 2020; 87: 29-47
Year: 2020

Quantitative proteomic analysis: methods and applications
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004

In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020

Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008

In silico model of the spectrum of reactivity to mycobacteria
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Use of biomaterials to tissue engineer 3D models with lung organoids for in-vitro disease modelling
Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions
Year: 2020

An integrated culture system for in vitro human airway modeling
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

Effects of anti-IL-5 receptor alpha in an ex vivo 3D model of COPD
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019